Position in NTRA
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$41,531
+$34,932 QoQ
Shares Held
153
+363.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#705
of 844 holders
Holding Since
Jun 2021
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026TD PRIVATE CLIENT WEALTH LLC holds $10,628,400 across 18 Diagnostics & Research names. NTRA ranks #12 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
10,103 | $5,065,240 | |
| 2 | DHR |
Danaher Corp /De/
|
12,142 | $2,312,808 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
5,188 | $1,002,425 | |
| 4 | DGX |
Quest Diagnostics Inc
|
2,806 | $594,731 | |
| 5 | LH |
Labcorp Holdings Inc.
|
1,318 | $369,040 | |
| 6 | A |
Agilent Technologies, Inc.
|
2,741 | $364,087 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
490 | $257,955 | |
| 8 | WAT |
Waters Corp /De/
|
616 | $231,024 |
All Filings in NTRA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41,531 | 153 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $6,599 | 33 | Shares | Defined | 2026-04-27 | |
| 2025-12-31 | $17,869 | 78 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $643 | 4 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $168 | 1 | Shares | Defined | 2025-07-15 | |
| 2021-12-31 | $653 | 7 | Shares | Defined | 2024-08-16 | |
| 2021-06-30 | $7,038 | 62 | Shares | Defined | 2024-08-16 | |
| No filing history on record for this holder in this stock. | ||||||